Koken Ltd. (JP:7963)
:7963
Want to see JP:7963 full AI Analyst Report?
Top Page
Koken Ltd.
(7963)
Select Model
Select Model
Rating:67Neutral
Price Target:
¥2,092.00
▲(12.72% Upside)
Action:Downgraded
Date:02/18/26
The score is held back primarily by weak and volatile cash generation in 2025 (negative free cash flow and low operating cash flow versus earnings). Offsetting this, the stock shows a constructive technical uptrend and appears attractively valued with a low P/E and moderate dividend yield, while leverage remains manageable.
Positive Factors
Improving leverage and balance-sheet resilience
Declining debt-to-equity and a stronger equity base materially improve financial flexibility and lower refinancing risk. This durable balance-sheet strength supports capital allocation for R&D, capacity or M&A over the next several quarters even if cash flow remains uneven.
Negative Factors
Weak and volatile cash generation
A sharp deterioration to negative free cash flow and much lower operating cash flow undermines earnings quality and internal funding capacity. Persistent cash volatility risks constraining capex, R&D, dividends or forcing external financing over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving leverage and balance-sheet resilience
Declining debt-to-equity and a stronger equity base materially improve financial flexibility and lower refinancing risk. This durable balance-sheet strength supports capital allocation for R&D, capacity or M&A over the next several quarters even if cash flow remains uneven.
Read all positive factors
Koken Ltd. (7963) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥8.94B
Dividend Yield1.89%
Average Volume (3M)4.09K
Price to Earnings (P/E)16.3
Beta (1Y)0.28
Revenue Growth6.09%
EPS Growth-6.33%
CountryJP
Employees321
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)157.22
Shares Outstanding5,104,003
10 Day Avg. Volume2,750
30 Day Avg. Volume4,086
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)0.66
Price to Sales (P/S)0.77
P/FCF Ratio-39.36
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Koken Ltd. Business Overview & Revenue Model
Company Description
Koken Ltd., together with its subsidiaries, produces and sells occupational personal protective and environment quality improvement equipment in Japan. It operates in Mask-Related Business, Environmental- Related Businesses, and Other Businesses s...
How the Company Makes Money
Koken Ltd. generates revenue through multiple streams, primarily from the sale of medical devices and healthcare technology solutions. The company earns money by selling its products directly to hospitals, clinics, and healthcare providers, as wel...
Koken Ltd. Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
74
Positive
Cash Flow
38
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.06B | 11.86B | 10.76B | 10.59B | 10.60B | 10.20B |
| Gross Profit | 5.12B | 5.38B | 4.92B | 4.84B | 4.99B | 4.65B |
| EBITDA | 1.54B | 1.69B | 1.45B | 1.50B | 1.78B | 1.61B |
| Net Income | 777.19M | 885.29M | 722.06M | 701.13M | 833.11M | 862.37M |
Balance Sheet | ||||||
| Total Assets | 20.83B | 22.44B | 20.95B | 20.87B | 20.62B | 19.64B |
| Cash, Cash Equivalents and Short-Term Investments | 3.02B | 2.68B | 2.53B | 2.98B | 2.39B | 2.19B |
| Total Debt | 5.51B | 5.79B | 5.18B | 6.05B | 6.13B | 6.13B |
| Total Liabilities | 7.71B | 8.65B | 7.91B | 8.52B | 8.80B | 8.52B |
| Stockholders Equity | 13.12B | 13.80B | 13.04B | 12.35B | 11.82B | 11.11B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -232.16M | 445.38M | 886.94M | 451.74M | 417.31M |
| Operating Cash Flow | 0.00 | 136.14M | 666.37M | 1.08B | 618.95M | 655.48M |
| Investing Cash Flow | 0.00 | -379.51M | -98.81M | -206.25M | -184.20M | 147.58M |
| Financing Cash Flow | 0.00 | 370.84M | -1.05B | -307.82M | -291.98M | -176.25M |
Koken Ltd. Technical Analysis
Negative
1856.00
Price Trends
1932.16
Negative
1925.00
Negative
1833.14
Negative
Market Momentum
-14.82
Positive
39.96
Neutral
18.71
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7963, the sentiment is Negative. The current price of 1856 is below the 20-day moving average (MA) of 1887.45, below the 50-day MA of 1932.16, and above the 200-day MA of 1833.14, indicating a bearish trend. The MACD of -14.82 indicates Positive momentum. The RSI at 39.96 is Neutral, neither overbought nor oversold. The STOCH value of 18.71 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7963.
Koken Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥43.53B | 7.62 | ― | 2.93% | 2.24% | 16.89% | |
78 Outperform | ¥17.91B | 15.06 | ― | 3.02% | 13.43% | 7.06% | |
72 Outperform | ¥10.20B | 15.65 | ― | 3.52% | 3.67% | -30.85% | |
67 Neutral | ¥8.94B | 16.33 | ― | 1.89% | 6.09% | -6.33% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | ¥18.67B | 53.77 | ― | 3.12% | -4.77% | ― | |
47 Neutral | ¥130.02B | 279.88 | 2.42% | 3.73% | 0.78% | -95.37% |
* Healthcare Sector Average
JP:7963
Koken Ltd.
1,818.00
189.20
11.62%
JP:6523
PHC Holdings Corp.
1,026.00
107.25
11.67%
JP:5187
Create Medic Co., Ltd.
1,121.00
204.53
22.32%
JP:6678
Techno Medica Co., Ltd.
2,101.00
367.69
21.21%
JP:6823
Rion Co., Ltd.
3,530.00
1,192.91
51.04%
JP:7600
Japan Medical Dynamic Marketing, Inc.
709.00
190.68
36.79%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.